Protara Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

Rhea-AI Summary

Protara Therapeutics, Inc. (Nasdaq: TARA) announced participation in a fireside chat at the Guggenheim Healthcare Talks Oncology Day on February 9, 2023, at 11:20 am ET in New York. The event aims to discuss the company’s efforts in developing transformative therapies for cancer and rare diseases. Protara’s lead program, TARA-002, is an investigational therapy for non-muscle invasive bladder cancer and lymphatic malformations. The webcast will be available on the Company’s website and archived for a limited period.

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks Oncology Day on Thursday, February 9, 2023 at 11:20 am ET in New York, New York.

The live webcast of the fireside chat can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived for a limited time following the presentation.

About Protara Therapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:

Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

FAQ

What is the date and time of Protara's fireside chat?

Protara Therapeutics' fireside chat is scheduled for February 9, 2023, at 11:20 am ET.

Where can I watch the Protara Therapeutics fireside chat?

The fireside chat can be accessed via the Events and Presentations section of Protara's website.

What is the focus of Protara Therapeutics' lead program, TARA-002?

TARA-002 is being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations.

What is the stock symbol for Protara Therapeutics?

The stock symbol for Protara Therapeutics is TARA.

What are some other therapies in Protara’s portfolio?

In addition to TARA-002, Protara's portfolio includes IV Choline Chloride for intestinal failure-associated liver disease.